At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
Our experience from the BioEntrepreneur School is that overseas graduates in the UK are much more interested in setting up their own companies than our home grown graduates.
